Drug Information for Consumers and Healthcare Professionals Food and Drug Law Institute Annual Meeting Alan Goldhammer, PhD Associate VP Regulatory Affairs.

Slides:

Advertisements

Similar presentations

Labeling Prescription Drugs for Physicians and Consumers 48 th Annual Conference Preparing for the Next Century of Food and Drug Regulation Food and Drug.

Advertisements

NCPIE CMI Initiative. Education Committee Members American Pharmacists Association First DataBank National Assn. of Boards of Pharmacy National Assn.

Devon Local Pharmaceutical Committees COMMUNITY PHARMACY POLICY AND DEVELOPMENTS Sue Taylor, Devon LPCs January 2004.

An Overview of Direct-to-Consumer Prescription Drug Promotion Nancy M. Ostrove, Ph.D. Risk Communication Advisory Committee May 15, 2008.

Structured Product Labeling Overview

To Err Really is Human: Misunderstanding Medication Labels Terry C. Davis, PhD LSUHSC-S Ruth Parker, MD Emory University.

SPL/DailyMed Jamboree Workshop October 28, 2013 Stephen A. Weitzman, J.D., LL.M.

Medication Guides Nancy M. Ostrove, Ph.D. Division of Drug Marketing, Advertising, and Communications.

Advertising of rx medicinal products to the general public The case MSD Sharpe & Dohme GmbH vs. Merckle GmbH (C-316/09) Judgment of the ECJ of 5 May 2011.

RAC Study Group Chapter 16

Governing Pharmaceutical Technologies in the Age of the Internet Nick Fox, Katie Ward and Alan O’Rourke University of Sheffield, UK.

FEDERAL REGULATIONS OF MEDICATIONS Food, Drug and Cosmetic Act Protect consumers from adulterated and misbranded foods, drugs, cosmetics, or devices.

1 Alvimopan RiskMAP Joyce Weaver, Pharm.D., BCPS Office of Surveillance and Epidemiology.

1 The FDA and Animal Drug Compounding Neal Bataller, DVM FDA/Center for Veterinary Medicine AAVPT 14 th Biennial Symposium, May 16-17, 2005, Rockville,

1 Monitoring medical prescription in the Opole Voivodeship Branch of the NFZ Roman Kolek M.D.

April 8, 2005FDLI Annual Conference 1 Labeling Prescription Drugs for Physicians and Consumers (FDA Perspective) Paul J. Seligman, MD, MPH Director, Office.

Direct-to-Consumer Advertising of Prescription Drugs: Looking Back, Looking Forward Kathryn J. Aikin, Ph.D. Division of Drug Marketing, Advertising and.

The London Older People Service Development Program (LOPSDP) The ‘Medicines Management’ Project (January to July 2003) Lelly Oboh Project Co-ordinator.

The basics about over-the-counter and prescription drugs. 1 Medicine 101.

CPRS/Pharmacy Laboratory Monitoring Project

Primary Care and Community Outreach Research VCOM Institutional Review Board Jim Mahaney, PhD Associate Dean for Biomedical Affairs, Virginia Campus Past.

Introducing the Medication Recording System Schedule Ed Castagna Mom & Pop’s Small Business Services.

“Delivering Therapeutic Agents” - Marketing and Communication Strategies of Drug Companies Safura Nantogmah.

Federal Laws CHAPTER 3. DRUG REGULATION Timeline highlights –Food Drug & Cosmetic (FDC) Act –Durham Humphrey Amendment –Poison Prevention Packaging Act.

And patient empowerment Renate Heinisch, Rapporteur EESC.

FDA Risk Management Workshop: Concept Paper: Risk Management Programs April 10, 2003 Gary C. Stein, Ph.D. Director of Federal Regulatory Affairs American.

Communication of Drug Safety Information Food and Drug Administration Center for Drug Evaluation & Research Public Hearing December 8, 2005.

1 PhRMA Guiding Principles - DTC About Prescription Medicines.

1 Patient Communications Presented by: Carol Rothkopf December 7, 2005.

+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.

1 ELECTRONIC PRESCRIBING AND APPLICATION OF NEW TECHNOLOGIES IN THE SPANISH PHARMACY Carmen Peña López Secretary General. General Spanish Council of Pharmacists.

Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao

FDA Public Meeting on Electronic Records and Signatures June 11, 2004 Presentation of the Industry Coalition on 21CFR Part 11 Alan Goldhammer, PhD Chair.

Codes of Conduct The International Pharmaceutical Regulatory & Compliance Congress and Best Practice Forum 6 June 2007 Heather Simmonds Director Prescription.

Using Medicines Safely (2:50) Click here to launch video Click here to download print activity.

Medication Therapy Management Programs in Community Pharmacy Community Pharmacy October 17, 2006 Kurt A. Proctor, Ph.D., RPh Chief Operating Officer Community.

Medication Error Reduction Principles in Practice Copyright © – Academy of Managed Care Pharmacy (AMCP)Slide 1.

“USAPI-PHARMACY ASSOCIATION - RESPONSE TO NCD ROADMAP” Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa 51 st 1-18 nov 2011 Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa.

Marketing Pharmaceutical Care Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy University of Andalas 2010.

AAHRPP ACCREDITATION (Association for the Accreditation of Human Protection Programs)

Compliant Connections in an Increasingly Connected Population Connecting platforms into one campaign.

July 15, Postmarketing Safety Evaluation of Approved Drugs and Risk Management Victor F. C. Raczkowski, MD, MS Director, Office of Drug Safety July.

1 Presentation of the Pharmaceutical Research and Manufacturers of America at FDA Part 15 Hearing on Communication of Drug Safety Information December.

October 28, F OOD AND DRUG ADMINISTRATION AMENDMENTS ACT OF 2007 (FDAAA) and Risk Evaluation and Mitigation Strategies (REMS) Presented to the Ninth.

Communication of Risk Information Public Hearing December 7 & 8 Testimony of the Coalition for Healthcare Communication.

Evaluating Consumer Comprehension of Prescription Drug Information Saul Shiffman, Ph.D. Senior Scientific Advisor, Pinney Associates Consulting to industry.

Suzanne Sechen, Ph.D. Leader, Ruminant Drugs Team Division of Production Drugs Office of New Animal Drug Evaluation, CVM Labeling Issues.

Jamie Bango Lindsey Croker Kristen Lantz Achidi Ndiforchu.

Given the progress that continues to be made in society’s battle against disease, patients are seeking more information about medical problems and potential.

Developing role of community pharmacy in responding to the needs of people with drug problems Karen Melville Principal Pharmacist TSMS NHS Tayside.

27 June 2000Victor F. C. Raczkowski, M.D.1 Risk-Management Options Victor F. C. Raczkowski, M.D., M.S. Gastrointestinal Drugs Advisory Committee 27 June.

Partners in Progress: Deciding to Participate in Parkinson’s Clinical Research.

Darragh O’Loughlin MPSI IPU Secretary General Irish Pharmaceutical Healthcare Association RDS, Dublin: 26 November 2013.

Prescription Drug Advertising

Role of Pharmacist in Quality and Integrated Care

Wireless Access SSID: cwag2017

Regulatory Updates Health Sciences Authority Singapore

CA Board of Pharmacy’s Communication Journey: Patient-Centered Labels

Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.

Using Medicines Safely (2:50)

CHAPTER 4 Information Management in Pharmacy.

Pharmacist- Career Opportunities

Tackling the U.S. opioid crisis using blockchain

Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.

National Pharmacy Practice Standards the Regulatory Role

Lesson Objectives 12/10/14 Today’s Objective:

Pharmacy practice experience I

Using Medicines Safely (2:50)

Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.

Compounded Drugs and Lack of Premarket FDA-Approval

Presentation transcript:

Drug Information for Consumers and Healthcare Professionals Food and Drug Law Institute Annual Meeting Alan Goldhammer, PhD Associate VP Regulatory Affairs Pharmaceutical Research and Manufacturers of America

Importance of Communication An Educated Patient must be Goal #1 Improved Health Outcomes from Maximizing the Benefit and Minimizing the Risk is the Desired Result

Basis of all Communication FDA-Approved Drug Label is the synthesis of all the information acquired from the drug development program. It provides the important information that physicians need to treat their patients.

Useful Consumer Information Comes in Many Forms Increases Patient Knowledge and Awareness about Disease States and Treatment Options Leads to Improved Health Outcomes

Role of Integrated Consumer Education Campaigns Awareness Depth of Education Physician / Patient discussions Compliance Mass-reach advertising (TV/Print/PR) Websites, toll-free numbers, patient education Physician visit / Write Rx Patient education on use of product Each media has different strengths and purpose in comprehensive communication campaign

Information Available at Dispensing Medication Guides Patient Package Inserts Consumer Medication Information

Paperless Labeling Industry Initiative to Move Beyond Paper Prescribing Information to Deliver a Fully Implemented Electronic System at Every US Dispensing Site

The Current Regulation 21 CFR § Prescription drugs for human use –A drug subject to the requirements of section 503(b)(1) of the act shall be exempt from section 502(f)(1) if all the following conditions are met: –(c)(1) Labeling on or within the package from which the drug is to be dispensed bears adequate information for its use, including...

The Current Product Less than User-Friendly Current??? Bizarre sizes –the scroll –the newspaper –the wallpaper Mouse-size print Not always retained in pharmacies New FDA Rule to Require Longer Labels is Pending

The Paperless Labeling Task Force Proposal The current labeling for all marketed prescription products to be available electronically at no cost to all dispensing locations. PDF versions, using free software, available for viewing or printing. Bar-coded labels would allow direct access to product-specific labeling

Advantages to Proposal Pharmacists will have access to the most recent labeling –Public Health Benefit Labeling would be readable on screen Pharmacist can quickly scan to section of interest No possible product misbranding due to package insert mix ups

User Requirements Readily Accessible Timely – label updates will be provided daily Comprehensive User Friendly Standardized Printable Rapid access codes (bar-coded)

User Requirements (contd.) Text cannot be changed Virus protected Cost-neutral to dispensing site Available at all dispensing sites

Status and Next Steps Proof of Concept Test (summer 03) Large Scale Field Test ( Nov 04-Feb 05) Work with FDA and other stakeholders on full scale implementation Commercial Rollout in 2006????

Priority Goals Talk to your doctor, pharmacist, or other health care professionals. Know your medicines. Read the label and follow directions. Avoid interactions. Monitor the medicines effects.